(19)
(11) EP 3 807 413 A1

(12)

(43) Date of publication:
21.04.2021 Bulletin 2021/16

(21) Application number: 19749864.5

(22) Date of filing: 17.06.2019
(51) International Patent Classification (IPC): 
C12N 15/86(2006.01)
A61K 48/00(2006.01)
(86) International application number:
PCT/US2019/037489
(87) International publication number:
WO 2019/245973 (26.12.2019 Gazette 2019/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.06.2018 US 201862686668 P
02.10.2018 US 201862740402 P
30.10.2018 US 201862752841 P
25.03.2019 US 201962823649 P
11.06.2019 US 201962860220 P

(71) Applicant: Research Institute at Nationwide Children's Hospital
Columbus, Ohio 43205 (US)

(72) Inventors:
  • RODINO-KLAPAC, Louise
    Groveport, OH 43125 (US)
  • MENDELL, Jerry, R.
    Columbus, OH 43235 (US)

(74) Representative: D Young & Co LLP 
120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY